StockData
Silo Pharma, Inc. logo

Silo Pharma, Inc. (SILO) stock

SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.89+0.18 (+10.53%)

Close on Nov 18, 2026Market cap $3.00MP/E –Yield –

Silo Pharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Silo Pharma's price to sales ratio was 38.4× on Nov 11, 2026, against 67.5× a year earlier. Over the last 4 years it ranged from 25.7× to 386.0×, with a median of 67.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202638.4×−10.9
2025Dec 31, 202549.3×−6.0
2024Dec 31, 202455.4×+5.7
2023Dec 29, 202349.7×−78.5
2021Oct 29, 2021128.2×−257.8
2020Oct 30, 2020386.0×–

More Silo Pharma figures

See a number that looks wrong?